The CE and TGA approval and excellent OSA clinical trial result has de-risk this to some extent but if FDA submission is rejected, the pps will go down.....how much, who knows.
rap chart, page-1643
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #